EWC | MXE | EWC / MXE | |
Gain YTD | 17.433 | 33.499 | 52% |
Net Assets | 3.12B | 59M | 5,295% |
Total Expense Ratio | 0.50 | 1.51 | 33% |
Turnover | 4.00 | 166.37 | 2% |
Yield | 1.85 | 2.21 | 84% |
Fund Existence | 29 years | 35 years | - |
EWC | MXE | |
---|---|---|
RSI ODDS (%) | 2 days ago77% | 2 days ago79% |
Stochastic ODDS (%) | 2 days ago80% | 2 days ago87% |
Momentum ODDS (%) | 2 days ago85% | 2 days ago86% |
MACD ODDS (%) | 2 days ago81% | 2 days ago77% |
TrendWeek ODDS (%) | 2 days ago85% | 2 days ago89% |
TrendMonth ODDS (%) | 2 days ago83% | 2 days ago86% |
Advances ODDS (%) | 4 days ago85% | 2 days ago90% |
Declines ODDS (%) | 19 days ago81% | 11 days ago87% |
BollingerBands ODDS (%) | 2 days ago68% | 2 days ago77% |
Aroon ODDS (%) | 2 days ago77% | 2 days ago87% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WBCIX | 16.98 | 0.13 | +0.77% |
William Blair Small-Mid Cap Core I | |||
GALLX | 21.49 | 0.08 | +0.37% |
Goldman Sachs Enhanced U.S. Equity A | |||
BISRX | 25.79 | 0.05 | +0.19% |
Brandes International Small Cap EquityR6 | |||
PHPSX | 19.97 | 0.01 | +0.05% |
ProFunds Pharmaceuticals UltraSector Svc | |||
REEIX | 15.50 | -0.06 | -0.39% |
RBC Emerging Markets Equity I |
A.I.dvisor tells us that MXE and AC have been poorly correlated (+-11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MXE and AC's prices will move in lockstep.